However, PD-L1 expression is controlled by complex pathways (gene mutations, transcription, mRNA stability, oncogenes, protein stability) and does not necessarily correlate with anti-tumor CD8+ T cell responses [23]. This evidence concerns the gene CD274 and neoplasm.